Citation Impact
Citing Papers
HCV Persistence and Immune Evasion in the Absence of Memory T Cell Help
2003 StandoutScienceNobel
Disruption of MyD88 signaling suppresses hemophagocytic lymphohistiocytosis in mice
2011 StandoutNobel
Memory CD8 + T Cells Are Required for Protection from Persistent Hepatitis C Virus Infection
2003 StandoutNobel
Genetic Immunization
1996
Threonine 180 Is Required for G-protein-coupled Receptor Kinase 3- and β-Arrestin 2-mediated Desensitization of the μ-Opioid Receptor in Xenopus Oocytes
2001
A Toll-like receptor recognizes bacterial DNA
2000 StandoutNature
DNA-Based Vaccine against La Crosse Virus: Protective Immune Response Mediated by Neutralizing Antibodies and CD4+ T Cells
1999
Hepatitis B Virus Infection — Natural History and Clinical Consequences
2004 Standout
Hepatitis C Virus and eliminating post-transfusion hepatitis
2000 StandoutNobel
Modulating gene expression using DNA vaccines with different 3′-UTRs influences antibody titer, seroconversion and cytokine profiles
2003
IL-1 and Allergy
2010
Hepatitis C Virus Infection
2001 Standout
Microparticle-mediated RNA immunization against bovine viral diarrhea virus
2001
mRNA-based therapeutics — developing a new class of drugs
2014 StandoutNobel
The influence of natural products upon drug discovery (Antiquity to late 1999)
2000
The Pictet–Spengler Reaction in Nature and in Organic Chemistry
2011 Standout
Direct Catalytic Asymmetric Three‐Component Kabachnik–Fields Reaction
2008 StandoutNobel
Interferon-γ –Receptor Deficiency in an Infant with Fatal Bacille Calmette–Guérin Infection
1996
Influence of cellular location of expressed antigen on the efficacy of DNA vaccination: cytotoxic T lymphocyte and antibody responses are suboptimal when antigen is cytoplasmic after intramuscular DNA immunization
1997
Protective Immune Response to Hepatitis C Virus in Chimpanzees Rechallenged Following Clearance of Primary Infection
2001 StandoutNobel
Prospects for a vaccine against the hepatitis C virus
2005 StandoutNatureNobel
Liver-Derived Hepatitis C Virus (HCV)-Specific CD4+ T Cells Recognize Multiple HCV Epitopes and Produce Interferon Gamma
2000 StandoutNobel
Achiral Ligands Dramatically Enhance Rate and Enantioselectivity in the Rh/Phosphoramidite‐Catalyzed Hydrogenation of α,β‐Disubstituted Unsaturated Acids
2005 StandoutNobel
Bacterial CpG DNA Activates Immune Cells to Signal Infectious Danger
1999
Proenkephalin A gene products activate a new family of sensory neuron–specific GPCRs
2002
Bioavailability and Transport of Peptides and Peptide Drugs into the Brain
1997
Thionation of segetalins A and B, cyclic peptides with estrogen-like activity from seeds of Vaccaria segetalis
1997
Macrophage plasticity and polarization: in vivo veritas
2012 Standout
Recurrence of hepatitis C virus after loss of virus-specific CD4+ T-cell response in acute hepatitis C
1999
Structure of the δ-opioid receptor bound to naltrindole
2012 StandoutNatureNobel
The efficacy of DNA vaccination is enhanced in mice by targeting the encoded protein to dendritic cells
2008 StandoutNobel
Unusual thionation of a cyclic hexapeptide
1992
Strategies and Prospects for Vaccination Against the Hepatitis C Viruses
2000 StandoutNobel
Seven-transmembrane receptors
2002 StandoutNobel
Nanoparticles, Proteins, and Nucleic Acids: Biotechnology Meets Materials Science
2001 Standout
Recent advances in selective opioid receptor agonists and antagonists
2003
Experimental and Computational Analyses of the Energetic Basis for Dual Recognition of Immunity Proteins by Colicin Endonucleases
2008 StandoutNobel
The immunoglobulin constant region contributes to affinity and specificity
2008
Interferon-γ and interleukin-12 pathway defects and human disease
2000
An Official ATS/IDSA Statement: Diagnosis, Treatment, and Prevention of Nontuberculous Mycobacterial Diseases
2007 Standout
Enhanced Morphine Analgesia in Mice Lacking β-Arrestin 2
1999 StandoutScienceNobel
Toll-Like Receptors
2003 Standout
IFN-γ Is Required for Viral Clearance from Central Nervous System Oligodendroglia
1999
Evaluation of Hepatitis C Virus Glycoprotein E2 for Vaccine Design: an Endoplasmic Reticulum-Retained Recombinant Protein Is Superior to Secreted Recombinant Protein and DNA-Based Vaccine Candidates
2000 StandoutNobel
Chapter 28 Sites of action of opiates in production of analgesia
1988
Solid-Phase Intramolecular N-Acyliminium Pictet−Spengler Reactions as Crossroads to Scaffold Diversity
2004 StandoutNobel
Flying Under the Radar: The Immunobiology of Hepatitis C
2006 StandoutNobel
Effect of Anti-CXCL10 Monoclonal Antibody on Herpes Simplex Virus Type 1 Keratitis and Retinal Infection
2003
Unresponsiveness to Cannabinoids and Reduced Addictive Effects of Opiates in CB 1 Receptor Knockout Mice
1999 StandoutScience
Gene vaccination with naked plasmid DNA: mechanism of CTL priming.
1996
HOW CELLS RESPOND TO INTERFERONS
1998 Standout
Gamma Interferon (IFN-γ) Receptor Null-Mutant Mice Are More Susceptible to Herpes Simplex Virus Type 1 Infection than IFN-γ Ligand Null-Mutant Mice
1999
Engineered Biosynthesis of β‐Alkyl Tryptophan Analogues
2018 StandoutNobel
CD4+T-Cell Effectors Inhibit Epstein-Barr Virus-Induced B-Cell Proliferation
2001
Dendritic Cells Initiate Immune Control of Epstein-Barr Virus Transformation of B Lymphocytes In Vitro
2003 StandoutNobel
Antigen Presentation by Dendritic Cells after Immunization with DNA Encoding a Major Histocompatibility Complex Class II–restricted Viral Epitope
1997 StandoutNobel
Enhancement of Sindbis Virus Self-Replicating RNA Vaccine Potency by Linkage ofMycobacterium tuberculosisHeat Shock Protein 70 Gene to an Antigen Gene
2001 StandoutNobel
Precipitation of morphine withdrawal syndrome in rats by administration of mu-, delta- and kappa-selective opioid antagonists
1992
Inhibition of Hepatitis B Virus Replication during Adenovirus and Cytomegalovirus Infections in Transgenic Mice
1998
Use of Lawesson's Reagent in Organic Syntheses
2007 Standout
[2‘,6‘-Dimethyltyrosine]Dynorphin A(1−11)-NH2Analogues Lacking an N-Terminal Amino Group: Potent and Selective κ Opioid Antagonists
2001
A new approach to the epimeric analogue of cyclic peptides: epimerisation via oxazoles of RA-VII, an anti-tumour bicyclic hexapeptide from Rubia plants
2001
IFN-gamma is required for viral clearance from central nervous system oligodendroglia.
1999
CD4+T cell-mediated control of a γ-herpesvirus in B cell-deficient mice is mediated by IFN-γ
1999 Nobel
Evidence for Differential Roles for NKG2D Receptor Signaling in Innate Host Defense against Coronavirus-Induced Neurological and Liver Disease
2007 StandoutNobel
A Field Guide to Foldamers
2001 Standout
DNA Immunization against Herpes Simplex Virus: Enhanced Efficacy Using a Sindbis Virus-Based Vector
1998
Kinetics of CD4+and CD8+Memory T-Cell Responses during Hepatitis C Virus Rechallenge of Previously Recovered Chimpanzees
2003 StandoutNobel
Reduction of Retrovirus-Induced Immunosuppression by In Vivo Modulation of T Cells during Acute Infection
2004 StandoutNobel
HIV Gag mRNA Transfection of Dendritic Cells (DC) Delivers Encoded Antigen to MHC Class I and II Molecules, Causes DC Maturation, and Induces a Potent Human In Vitro Primary Immune Response
2000 StandoutNobel
Impact of Natural Products on Developing New Anti-Cancer Agents
2009 Standout
Interferon-Stimulated Gene (ISG)-Expression Screening Reveals the Specific Antibunyaviral Activity of ISG20
2018 StandoutNobel
Expression of CXC Chemokine Ligand 10 from the Mouse Hepatitis Virus Genome Results in Protection from Viral-Induced Neurological and Liver Disease
2007 StandoutNobel
Role of the E2 Hypervariable Region (HVR1) in the Immunogenicity of a Recombinant Hepatitis C Virus Vaccine
2018 StandoutNobel
DESENSITIZATION OF G PROTEIN–COUPLED RECEPTORS AND NEURONAL FUNCTIONS
2004 StandoutNobel
Peptidomimetics for Receptor Ligands—Discovery, Development, and Medical Perspectives
1993
Human Cd4+ T Lymphocytes Consistently Respond to the Latent Epstein-Barr Virus Nuclear Antigen Ebna1
2000 StandoutNobel
Preferential induction of a Th1 immune response and inhibition of specific IgE antibody formation by plasmid DNA immunization.
1996
Novel Recombinant Parapoxvirus Vectors Induce Protective Humoral and Cellular Immunity against Lethal Herpesvirus Challenge Infection in Mice
2003
DNA VACCINES
1997
Studies on Rubia akane(RA) derivatives. Part 7. Thioamide analogues of RAs: antitumour cyclic hexapeptides
1994
Nonproliferating Bystander CD4+ T Cells Lacking Activation Markers Support HIV Replication During Immune Activation
2001 StandoutNobel
Noncytopathic Sindbis virus RNA vectors for heterologous gene expression
1998 StandoutNobel
Enhancement of immune response to naked DNA vaccine by immunization with transfected dendritic cells
1997
C7L Family of Poxvirus Host Range Genes Inhibits Antiviral Activities Induced by Type I Interferons and Interferon Regulatory Factor 1
2012 StandoutNobel
Peptide Science: Exploring the Use of Chemical Principles and Interdisciplinary Collaboration for Understanding Life Processes
2003
Towards control of χ-space: Conformationally constrained analogues of Phe, Tyr, Trp and His
1999
In Vivo Protein Transduction: Delivery of a Biologically Active Protein into the Mouse
1999 StandoutScience
Bystander activation of CD4+ T cells accounts for herpetic ocular lesions.
2000
Characterization of Hepatitis C Virus Core-Specific Immune Responses Primed in Rhesus Macaques by a Nonclassical ISCOM Vaccine
2001 StandoutNobel
Works of William S. Wire being referenced
Induction of Protective Immunity against Herpes Simplex Virus with DNA Encoding the Immediate Early Protein ICP 27
1995
Design and synthesis of somatostatin analogs with topographical properties that lead to highly potent and specific .mu. opioid receptor antagonists with greatly reduced binding at somatostatin receptors
1988
Biological activities of cyclic enkephalin pseudopeptides containing thioamides as amide bond replacements
1989
Syntheses, opioid binding affinities, and potencies of dynorphin A analogues substituted in positions 1, 6, 7, 8 and 10
1993
Novel peptidic mu opioid antagonists: pharmacologic characterization in vitro and in vivo.
1989
Genetic immunization against herpes simplex virus. Protection is mediated by CD4+ T lymphocytes
1995
Meptazinol: Unusual in vivo opioid receptor activity at supraspinal and spinal sites
1986
Proenkephalin A fragments exhibit spinal and supraspinal opioid activity in vivo.
1985
Characterization of herpes simplex virus type-1 infection and herpetic stromal keratitis development in IFN-γ knockout mice
1995